Services
Neeman & Industry News
DCGI to implement e-Gov in its working The Drugs Controller General of India (DCGI) to have a single window facility for drug approval soon...
New Indian Regulatory Guidance by Central Drugs Standard Control Organization Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy - Central Drugs Standard Control Organization...
Indian Clinical Data Management market is expected to ramp up to $150 million MNCs are more than willing to outsource their needs to India because of it\'s technological innovation, creditable quality, operational flexibility, cost effectiveness, time-to-market and competitive advantage according to Koteshwar Govind, Deputy Manager,...
India: Attractive Market for Biopharmaceutical Companies Looking to Accelerate Their Clinical Trials The Clinical Research Market in India is growing at a very rapid rate according to anyone’s statistics…It is exploding according to all the hype. ...

Monitoring Services » Monitoring


Site Qualification Visit:

Site qualification visits to check:
Site Initiation Visit

Site initiation visit to confirm:
Interim Monitoring Visit

The following issues are addressed at each interim visit as appropriate:
Study Close-Out Visit:

The study close-out activities of a clinical research protocol are as important to complete as the initial approval and study start up process.  At the completion of the study the Principal Investigator is responsible for ensuring the appropriate close-out activities are completed and the proper institutional offices are notified.
             
During the Close out of a trial, following issues are addressed